Empowering Oncology Decisions

DiagnoCure is a life sciences company that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions.

Special Announcement

FDA APPROVES PROGENSA PCA3 ASSAY

Visit our media room for more information